Literature DB >> 7758487

In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan.

P R Hsueh, J C Chang, S C Chang, S W Ho, W C Hsieh.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7758487     DOI： 10.1007/BF02111880

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Antibiotic susceptibilities of the Vibrionaceae to meropenem and other antimicrobial agents.

Authors:  R B Clark
Journal:  Diagn Microbiol Infect Dis       Date:  1992-07       Impact factor: 2.803

2.  Antimicrobial susceptibilities of halophilic vibrios.

Authors:  G L French; M L Woo; Y W Hui; K Y Chan
Journal:  J Antimicrob Chemother       Date:  1989-08       Impact factor: 5.790

3.  Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients.

Authors:  S D Park; H S Shon; N J Joh
Journal:  J Am Acad Dermatol       Date:  1991-03       Impact factor: 11.527

4.  Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987.

Authors:  K C Klontz; S Lieb; M Schreiber; H T Janowski; L M Baldy; R A Gunn
Journal:  Ann Intern Med       Date:  1988-08-15       Impact factor: 25.391

Review 5.  Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment.

Authors:  Y C Chuang; C Y Yuan; C Y Liu; C K Lan; A H Huang
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

6.  Vibrio vulnificus. Man and the sea.

Authors:  J M Johnston; S F Becker; L M McFarland
Journal:  JAMA       Date:  1985-05-17       Impact factor: 56.272

7.  Virulence of Vibrio vulnificus strains from marine environments.

Authors:  D L Tison; M T Kelly
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

8.  In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.

Authors:  J G Morris; J H Tenney; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
  8 in total
  6 in total

1.  Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus.

Authors:  Tsai-Nung Kuo Chou; Wai-Nang Chao; Cheng Yang; Ruey-Hong Wong; Kwo-Chang Ueng; Shiuan-Chih Chen
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

2.  In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.

Authors:  Y C Chuang; J W Liu; W C Ko; K Y Lin; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

3.  Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

Authors:  Y C Chuang; W C Ko; S T Wang; J W Liu; C F Kuo; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 4.  Vibrio vulnificus in Taiwan.

Authors:  Po-Ren Hsueh; Ching-Yih Lin; Hung-Jen Tang; Hsin-Chun Lee; Jien-Wei Liu; Yung-Ching Liu; Yin-Ching Chuang
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

5.  Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.

Authors:  Seong Eun Kim; Sung Un Shin; Tae Hoon Oh; Uh Jin Kim; Kalifa Sanneh Darboe; Seung-Ji Kang; Hee-Chang Jang; Sook-In Jung; Hee-Young Shin; Kyung-Hwa Park
Journal:  PLoS Negl Trop Dis       Date:  2019-06-12

6.  Vibrio Vulnificus Necrotizing Fasciitis Associated with Acupuncture.

Authors:  Yael Kotton; Soboh Soboh; Naiel Bisharat
Journal:  Infect Dis Rep       Date:  2015-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.